SEC Form D · filed March 9, 2017
Arix Bioscience plc
Industry
Other Health Care
Location
LONDON, United Kingdom
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
John E. Decooman · Vancouver, British Columbia, CanadaDirectorMoshe Schreiber · Cedarhurst, NYDirectorDavid U'Prichard · LONDON, United KingdomDirectorThomas E. Willingham · Richmond, VADirectorHernan M. Zaballa · Vancouver, British Columbia, CanadaExec · DirectorAnthony Young · Los Angeles, CADirectorJames Rawlingson · LONDON, United KingdomExec · DirectorNicole M. Breen · Tucson, AZExec · DirectorPatrick E. Williams · La Veta, COExec · DirectorRyan Krafft · Sherborn, MADirectorFranz Humer · LONDON, United KingdomDirectorDavid E. Doherty · Vancouver, British Columbia, CanadaDirectorYosef Katz · Cedarhurst, NYExec · DirectorJonathan Peacock · LONDON, United KingdomExec · DirectorAslam Merchant · ATLANTA, GAExec · DirectorCassandra E. Gee · Vancouver, British Columbia, CanadaExec · DirectorWillem Fuchter · Vancouver, British Columbia, CanadaDirectorJohn Mutton Of Furness · LONDON, United KingdomDirectorJoseph Anderson · LONDON, United KingdomExec · DirectorGlenn E. Martin · Tucson, AZExec · DirectorZula E. Kropivnitski · Vancouver, British Columbia, CanadaDirectorEduardo E. Perlicz · Vancouver, British Columbia, CanadaDirectorJohn Banham · LONDON, United KingdomDirectorTrevor Jones · LONDON, United KingdomDirectorChristopher Evans · LONDON, United KingdomExec · DirectorLindsey Krystofiak · SAN FRANCISCO, CADirectorCarlos E. Ponte · Vancouver, British Columbia, CanadaExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗